NEW YORK (GenomeWeb News) — The US Food and Drug Administration “might not” pursue genetic label changes “as aggressively as it had in the past,” and instead hopes to focus more on how biomarkers affect drug safety and efficacy, according to a senior FDA official.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.